# Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental

> **NCT00404833** · PHASE3 · COMPLETED · sponsor: **Hospital Authority, Hong Kong** · enrollment: 16 (estimated)

## Conditions studied

- Glomerulonephritis, Membranous
- Glomerulosclerosis, Focal

## Interventions

- **DRUG:** prednisolone and mycophenolate mofetil
- **DRUG:** prednisolone and chlorambucil

## Key facts

- **NCT ID:** NCT00404833
- **Lead sponsor:** Hospital Authority, Hong Kong
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2013-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00404833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00404833, "Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00404833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*